Atlas Antibodies: an Extraordinary Story
Atlas Antibodies is a dynamic Swedish Life Science company dedicated to contributing to increase health and well-being globally by advancing protein science & medical discovery.
Atlas Antibodies was founded in 2006 by researchers from the prestigious Human Protein Atlas project (a Wallenberg funded project), with the aim to make the unique antibodies used in the project available to fellow researchers worldwide.
Based on the idea to create a complete map of human protein expression and localization, the Human Protein Atlas project developed its own set of highly specific antibodies.
These unique antibodies were made commercially available in 2006 by Atlas Antibodies as Triple A (Atlas Antibodies Advanced) Polyclonals. Since then, Atlas Antibodies has also introduced PrecisA Monoclonals (the swedish word "precisa" stands for precise, accurate and targeted) and PrEST Antigens (recombinant human Protein Epitope Signature Tags). All of these products are based on the same high-quality manufacturing principles.
In 2024 Atlas Antibodies has released MolBoolean, a new technology for protein-protein interaction studies.
Our products are used in research for the purpose of understanding and improving human health. Atlas Antibodies is fully owned by Patricia Industries (an Investor company) and follow the high standards of the Investor group and have a high focus on sustainability in all things we do.